Health & Safety Industry Today

Alpha Thalassemia 2018 Global Market Challenge, Driver, Trends & Forecast to 2023

Pune, India, 29th August 2018: WiseGuyReports announced addition of new report, titled “Alpha Thalassemia Market Research Report - Global Forecast till 2023”.
Published 29 August 2018
Report Description
This report analyzes the alpha thalassemia market by type (hb bart syndrome, hbh disease, silent carrier state, and trait.), by diagnosis (perinatal testing, prenatal testing, and pre-implantation), by treatment, by end user; it also studies the top manufacturers in the market.
The alpha thalassemia market is expected to grow at a CAGR of approximately 8.8% during the forecast period 2017-2023.
The major players in alpha thalassemia market include:
•             GlaxoSmithKline Plc
•             Celgene
•             Bellicum Pharmaceuticals
•             Lonza group
•             Acceleron Pharma
•             BlueBird Bio
•             Sangamo Biosciences
•             Pharmaceuticals Inc
•             Alnylam Pharmaceuticals Inc
•             Calimmune Inc
•             CRISPR Therapeutics
•             Editas Medicine Inc
•             Errant Gene Therapeutics LLC
•             Gamida Cell Ltd
•             Gilead Sciences Inc
•             Incyte Corp
•             Ionis Pharmaceuticals Inc
•             IRBM Science Park SpA
•             Johnson & Johnson
•             Kiadis Pharma NV
•             La Jolla Pharmaceutical Company
•             Merck & Co Inc
•             PharmaEssentia Corp
•             Protagonist Therapeutics Inc
•             Sangamo Therapeutics Inc
•             Zydus Cadila Healthcare Ltd.
The market revenue and share have been analyzed with respect to the following regions and countries:
North America
South America
Western Europe
Rest of Western Europe
Eastern Europe
Republic of Korea
Rest of Asia-Pacific
Middle East & Africa
United Arab Emirates
Saudi Arabia
Rest of The Middle East & Africa
On the basis of type, the alpha thalassemia market has been categorized into the following segments:
•             HB bart syndrome
•             HBH disease
•             Silent carrier state
•             Trait
On the basis of diagnosis, the alpha thalassemia market has been categorized into the following segments:
•             Perinatal testing
•             Prenatal testing
•             Pre-implantation
On the basis of treatment, the alpha thalassemia market has been categorized into the following segments:
•             Blood transfusions
•             Iron chelation
•             Bone marrow
•             Stem cell transplant
•             Surgery and gene therapy
On the basis of end user, the alpha thalassemia market has been categorized into the following segments:
•             Hospitals
•             Biotechnological laboratories
•             Diagnostic laboratories
•             Educational research institutes
•             Pharmaceutical industries
•             Others
Research Methodology
Analysis is conducted by industry experts who offer insight into industry structure, market segmentation, technology assessment, competitive landscape (CL), and market penetration, as well as on emerging trends. Besides primary interviews (~80%) and secondary research (~20%), their analysis is based on years of professional expertise in their respective industries. Our analysts also predict where the market will be headed in the next five to 10 years, by analyzing historical trends and current market positions. Furthermore, the varying trends of segments and categories in different regions are estimated based on primary and secondary research.
Both the top-down and bottom-up approaches were used to estimate and validate the size of the market and to estimate the size of various other dependent sub-markets. The key players in the market were identified through secondary research, and their market contributions in the respective regions were determined through primary and secondary research. This entire process included the study of the annual and financial reports of the top market players and extensive interviews for key insights with industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares, splits, and breakdowns were determined using secondary sources and verified through primary sources. All the possible parameters that affect the market covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to arrive at the final quantitative and qualitative data.
Table of Content: Key Points
Chapter 1. Report Prologue
Chapter 2. Market Introduction
Chapter 3. Research Methodology
Chapter 4. Market Dynamics
Chapter 5. Market Factor Analysis
Chapter 6. Global Alpha Thalassemia Market, By Type
Chapter 7. Global Alpha Thalassemia Market, By Diagnosis
ACCESS REPORT @                
Contact Info:                                                         
NORAH TRENT                                                          
Ph: +1-646-845-9349 (US)                         
Ph: +44 208 133 9349 (UK)                                                 
Get in touch:                                                          

Other Industry News

Ready to start publishing

Sign Up today!